NCT06637306 2026-05-14Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast CancerIcahn School of Medicine at Mount SinaiPhase EARLY_PHASE1 Recruiting15 enrolled